SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-046316
Filing Date
2017-07-21
Accepted
2017-07-21 16:39:59
Documents
1
Period of Report
2017-06-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a17-18213_18k.htm 8-K 20723
  Complete submission text file 0001104659-17-046316.txt   21949
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640
Nabriva Therapeutics Legacy plc (Filer) CIK: 0001703287 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38132 | Film No.: 17976955
SIC: 2834 Pharmaceutical Preparations